Chiharu Takahashi1,2, Makoto Kurano1,2, Masako Nishikawa1,2, Kuniyuki Kano2,3, Tomotaka Dohi4, Katsumi Miyauchi4, Hiroyuki Daida4, Tomo Shimizu5, Junken Aoki2,3, Yutaka Yatomi1,2. 1. Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo. 2. CREST, Japan Science and Technology Corporation (JST). 3. Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University. 4. Department of Cardiovascular Medicine, Juntendo University School of Medicine. 5. Tsukuba Research Institute, Research & Development Division, Sekisui Medical Co., Ltd.
Abstract
AIM: Sphingosine 1-phosphate (S1P) has been suggested to be a positive regulator of plasminogen activator inhibitor 1 (PAI-1) in adipocytes, while some studies are not consistent with this prothrombotic property of S1P. Since S1P is bound to apolipoprotein M (apoM) on HDL or to albumin in plasma, we compared the properties of these two forms on the PAI-1 induction. METHODS: We investigated the associations of S1P, apoM, and PAI-1 concentrations in the plasma of normal coronary artery (NCA), stable angina pectoris (SAP), and acute coronary syndrome (ACS) subjects (n=32, 71, and 38, respectively). Then, we compared the effects of S1P with various vehicles on the PAI-1 expression in 3T3L1 adipocytes. We also investigated the modulation of the PAI-1 levels in mice infected with adenovirus coding apoM. RESULTS: Among ACS subjects, the PAI-1 level was positively correlated with the S1P level, but not the apoM level. In adipocytes, S1P bound to an apoM-rich vehicle induced PAI-1 expression to a lesser extent than the control vehicle, while S1P bound to an apoM-depleted vehicle induced PAI-1 expression to a greater extent than the control vehicle in 3T3L1 adipocytes. Additionally, apoM overexpression in mice failed to modulate the plasma PAI-1 level and the adipose PAI-1 expression level. S1P bound to albumin increased PAI-1 expression through the S1P receptor 2-Rho/ROCK-NFκB pathway. CONCLUSION: S1P bound to albumin, but not to apoM, induces PAI-1 expression in adipocytes, indicating that S1P can exert different properties on the pathogenesis of vascular diseases, depending on its vehicle.
AIM: Sphingosine 1-phosphate (S1P) has been suggested to be a positive regulator of plasminogen activator inhibitor 1 (PAI-1) in adipocytes, while some studies are not consistent with this prothrombotic property of S1P. Since S1P is bound to apolipoprotein M (apoM) on HDL or to albumin in plasma, we compared the properties of these two forms on the PAI-1 induction. METHODS: We investigated the associations of S1P, apoM, and PAI-1 concentrations in the plasma of normal coronary artery (NCA), stable angina pectoris (SAP), and acute coronary syndrome (ACS) subjects (n=32, 71, and 38, respectively). Then, we compared the effects of S1P with various vehicles on the PAI-1 expression in 3T3L1 adipocytes. We also investigated the modulation of the PAI-1 levels in mice infected with adenovirus coding apoM. RESULTS: Among ACS subjects, the PAI-1 level was positively correlated with the S1P level, but not the apoM level. In adipocytes, S1P bound to an apoM-rich vehicle induced PAI-1 expression to a lesser extent than the control vehicle, while S1P bound to an apoM-depleted vehicle induced PAI-1 expression to a greater extent than the control vehicle in 3T3L1 adipocytes. Additionally, apoM overexpression in mice failed to modulate the plasma PAI-1 level and the adipose PAI-1 expression level. S1P bound to albumin increased PAI-1 expression through the S1P receptor 2-Rho/ROCK-NFκB pathway. CONCLUSION:S1P bound to albumin, but not to apoM, induces PAI-1 expression in adipocytes, indicating that S1P can exert different properties on the pathogenesis of vascular diseases, depending on its vehicle.
Entities:
Keywords:
Apolipoprotein M; Plasminogen activator inhibitor 1; Sphingosine 1-phosphate
Authors: Christina Christoffersen; Hideru Obinata; Sunil B Kumaraswamy; Sylvain Galvani; Josefin Ahnström; Madhumati Sevvana; Claudia Egerer-Sieber; Yves A Muller; Timothy Hla; Lars B Nielsen; Björn Dahlbäck Journal: Proc Natl Acad Sci U S A Date: 2011-05-23 Impact factor: 11.205
Authors: P Carmeliet; L Kieckens; L Schoonjans; B Ream; A van Nuffelen; G Prendergast; M Cole; R Bronson; D Collen; R C Mulligan Journal: J Clin Invest Date: 1993-12 Impact factor: 14.808
Authors: Baidong Hou; Mesut Eren; Corrie A Painter; Joseph W Covington; John D Dixon; John A Schoenhard; Douglas E Vaughan Journal: J Biol Chem Date: 2004-02-12 Impact factor: 5.157
Authors: Sylvain Galvani; Marie Sanson; Victoria A Blaho; Steven L Swendeman; Hideru Obinata; Heather Conger; Björn Dahlbäck; Mari Kono; Richard L Proia; Jonathan D Smith; Timothy Hla Journal: Sci Signal Date: 2015-08-11 Impact factor: 8.192
Authors: Kelley M Argraves; Amar A Sethi; Patrick J Gazzolo; Brent A Wilkerson; Alan T Remaley; Anne Tybjaerg-Hansen; Børge G Nordestgaard; Sharon D Yeatts; Katherine S Nicholas; Jeremy L Barth; W Scott Argraves Journal: Lipids Health Dis Date: 2011-05-09 Impact factor: 3.876
Authors: Cecília R Panta; Éva Ruisanchez; Dorottya Móré; Péter T Dancs; Andrea Balogh; Ágnes Fülöp; Margit Kerék; Richard L Proia; Stefan Offermanns; Gábor J Tigyi; Zoltán Benyó Journal: Int J Mol Sci Date: 2019-12-17 Impact factor: 5.923